Top Markets
Coin of the day
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Hisse Senetlerindeki Sıralama #37014
Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating... Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating therapies for the acute phase of thrombotic conditions. The company's lead compound, glenzocimab, is a humanized monoclonal antibody fragment specifically designed to target a particular platelet glycoprotein. Currently, Acticor Biotech is advancing two clinical programs, both in Phase II/III, for the registration of treatments for ischemic stroke. Additionally, it is conducting two other Phase II trials concerning significant cardiovascular emergencies, with anticipated clinical data expected from both its ischemic stroke research and studies related to COVID-19 respiratory distress syndrome. Established in 2013, the company operates from its headquarters in Paris, France.
Hisse Fiyatı
$0.25974701
Son senkronizasyon: 2025-01-06
Piyasa Değeri
$2.04M
Değişim (1 gün)
0.74%
Değişim (1 yıl)
0.00%
Ülke
FR
Ticaret Acticor Biotech SAS (ALACT)

Kategori

Acticor Biotech SAS (ALACT) için temettü verimi geçmişi
Acticor Biotech SAS (hisse sembolü: ALACT) temettü verimi (TTM) 2022-12-31 itibariyle: 0.00%
Son 5 yılın ortalama temettü verimi: 0.00%
Acticor Biotech SAS (ALACT) için 2010 - 2026 arası temettü verimi geçmişi
Her yılın sonunda temettü verimi (TTM)
Yıl Temettü Verimi Değiştir
2026 (TTM) 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
2010 0.00% 0.00%
Benzer şirketler veya rakiplerin temettü verimi (TTM)
Şirket Temettü Verimi Ülke
0.00%
US
0.00%
NL
2.36%
AU
0.00%
US
0.00%
CH